M&A Deal Summary

Elorac Acquires Gideon Pharmaceuticals

On April 15, 2016, Elorac acquired life science company Gideon Pharmaceuticals

Acquisition Highlights
  • This is Elorac’s 1st transaction in the Life Science sector.
  • This is Elorac’s 1st transaction in the United States.
  • This is Elorac’s 1st transaction in Illinois.

M&A Deal Summary

Date 2016-04-15
Target Gideon Pharmaceuticals
Sector Life Science
Buyer(s) Elorac
Deal Type Add-on Acquisition

Target

Gideon Pharmaceuticals

Vernon Hills, Illinois, United States
Gideon Pharmaceuticals, Inc. is a development-stage pharmaceutical products company.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Elorac

Vernon Hills, Illinois, United States

Category Company
Sector Life Science
DESCRIPTION

Elorac, Inc. is a specialty pharmaceutical company engaged in the development and commercialization of novel products for dermatology, allergy and oncology.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Illinois M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1